Finance

Lists
Why is ANNX up 7,02%?
Dive Deeper
ANNX:STO
Annexin Pharmaceuticals AB (publ)
8,54 SEK
+7,02%
(+0,56) 1D
6 նոյ, 10:34:35 GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ANNX...
Open
8,50 SEK
High
9,48 SEK
Low
8,00 SEK
Mkt. cap
74,98 մլն
Avg. vol.
7,99 հզր
Volume
14,53 հզր
52-wk high
26,99 SEK
52-wk low
6,24 SEK
EPS
-5,81 SEK
Shares outstanding
8,72 մլն
No. of employees
4
Open
8,50 SEK
High
9,48 SEK
Low
8,00 SEK
Mkt. cap
74,98 մլն
Avg. vol.
7,99 հզր
Volume
14,53 հզր
52-wk high
26,99 SEK
52-wk low
6,24 SEK
EPS
-5,81 SEK
Shares outstanding
8,72 մլն
No. of employees
4
News stories
From web sources and news partners
About Annexin Pharmaceuticals AB (publ)
CEO-
Employees4
Founded2014
Headquarters-
SectorHealth Care
Industry-
Websiteannexinpharma.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8,00 մլն
7,92 մլն
8,48 մլն
6,89 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,26 մլն
2,90 մլն
2,96 մլն
2,61 մլն
Operating expense
10,26 մլն
10,82 մլն
11,14 մլն
9,50 մլն
Total operating expenses
10,26 մլն
10,82 մլն
11,14 մլն
9,50 մլն
Operating income
-10,26 մլն
-10,82 մլն
-11,14 մլն
-9,50 մլն
Other non operating income
-
-
1,00 հզր
-
EBT including unusual items
-10,52 մլն
-10,52 մլն
-11,56 մլն
-9,49 մլն
EBT excluding unusual items
-10,52 մլն
-10,52 մլն
-11,56 մլն
-9,49 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-288,00 հզր
-
Net income
-10,52 մլն
-10,52 մլն
-11,56 մլն
-9,49 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
231,00 հզր
34,00 հզր
-
-
Interest expense
-
-
-
-
Net interest expenses
231,00 հզր
34,00 հզր
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,21 մլն
-10,77 մլն
-11,10 մլն
-9,45 մլն
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps